Document Classification

Section Type: METHODS

Text: Compared with the control group, the treatment group had greater changes in bone mass, bone markers, and hormones, including 1) bone mineral density (BMD) in total hip (0. 1 + / - 2. 1 vs. -2. 4 + / - 2. 5 %), trochanter (0. 2 + / - 3. 3 vs. -3. 3 + / - 3. 1 %), and intertrochanter (0. 3 + / - 2. 7 vs. -2. 7 + / -. 3. 0 %) ; 2) C-terminal telopeptide (12 + / - 35 vs. 101 + / - 79 %) and osteocalcin (-5 + / - 15 vs. 66 + / - 61 %) ; and 3) leptin (2 + / - 12 vs. -30 + / - 25 %) and estradiol (0. 1 + / - 14 % vs. -14 + / - 21 %) (all P < 0. 05).